Current Opinion in Neurobiology,
Journal Year:
2025,
Volume and Issue:
92, P. 102999 - 102999
Published: March 20, 2025
Guidance
of
nascent
axons
to
their
targets
is
mediated
by
attractive
and
repulsive
cues
that
activate
receptors
on
the
axonal
growth
cone.
The
number
ligand-receptor
interactions
implicated
in
axon
pathfinding
still
expanding,
large-scale
cell-surface
extracellular
protein
interactome
studies
have
revealed
extensive
crosstalk
between
signaling
axes
once
thought
act
independently.
This
raises
question
how
apparent
promiscuity
molecular
compatible
with
specific
outcomes
effects
cone
steering.
Structural
provided
insights
into
modularity
binding
shown
capacity
engage
multiple
ligands.
Here,
we
review
recent
findings
about
complexity
interaction
networks
for
guidance,
structures
complexes
reveal
mechanisms
may
specify
output.
Cellular and Molecular Life Sciences,
Journal Year:
2024,
Volume and Issue:
81(1)
Published: Feb. 9, 2024
Abstract
Metastasis
accounts
for
90%
of
cancer-related
deaths
among
the
patients.
The
transformation
epithelial
cells
into
mesenchymal
with
molecular
alterations
can
occur
during
epithelial–mesenchymal
transition
(EMT).
EMT
mechanism
accelerates
cancer
metastasis
and
drug
resistance
ability
in
human
cancers.
Among
different
regulators
EMT,
Wnt/β-catenin
axis
has
been
emerged
as
a
versatile
modulator.
Wnt
is
active
form
physiological
condition
due
to
function
GSK-3β
that
destructs
β-catenin,
while
ligand–receptor
interaction
impairs
increase
β-catenin
stability
promote
its
nuclear
transfer.
Regarding
oncogenic
Wnt/β-catenin,
upregulation
occurs
cancers
it
accelerate
EMT-mediated
resistance.
stimulation
by
binding
ligands
Frizzled
receptors
enhance
accumulation
cytoplasm
stimulates
related
genes
upon
translocation.
Wnt/β-catenin/EMT
implicated
augmenting
both
solid
hematological
tumors.
Wnt/EMT-mediated
promotes
malignant
behavior
tumor
cells,
causing
therapy
be
modulated
upstream
mediators
which
non-coding
RNAs
are
main
regulators.
Moreover,
pharmacological
intervention,
mainly
using
phytochemicals,
suppresses
Wnt/EMT
suppression.
Graphical
abstract
Cancer Discovery,
Journal Year:
2024,
Volume and Issue:
14(11), P. 2135 - 2161
Published: July 5, 2024
KRAS
inhibitors
demonstrate
clinical
efficacy
in
pancreatic
ductal
adenocarcinoma
(PDAC);
however,
resistance
is
common.
Among
patients
with
KRASG12C-mutant
PDAC
treated
adagrasib
or
sotorasib,
mutations
PIK3CA
and
KRAS,
amplifications
of
KRASG12C,
MYC,
MET,
EGFR,
CDK6
emerged
at
acquired
resistance.
In
cell
lines
organoid
models
the
KRASG12D
inhibitor
MRTX1133,
epithelial-to-mesenchymal
transition
PI3K-AKT-mTOR
signaling
associate
to
therapy.
MRTX1133
treatment
KrasLSL-G12D/+;
Trp53LSL-R172H/+;
p48-Cre
(KPC)
mouse
model
yielded
deep
tumor
regressions,
but
drug
ultimately
emerged,
accompanied
by
Kras,
Yap1,
Myc,
Cdk6,
Abcb1a/b,
co-evolution
drug-resistant
transcriptional
programs.
Moreover,
KPC
PDX
models,
mesenchymal
basal-like
states
displayed
increased
response
inhibition
compared
classical
state.
Combination
chemotherapy
significantly
improved
control
models.
Collectively,
these
data
elucidate
co-evolving
mechanisms
support
multiple
combination
therapy
strategies.
Significance:
Acquired
may
limit
impact
PDAC.
Using
samples
preclinical
we
define
heterogeneous
genetic
non-genetic
that
guide
approaches
improve
durability
promising
therapies
for
patients.
See
related
commentary
Marasco
Misale,
p.
2018.
PLoS Biology,
Journal Year:
2024,
Volume and Issue:
22(2), P. e3002487 - e3002487
Published: Feb. 7, 2024
Epithelial-to-mesenchymal
transition
(EMT),
a
biological
phenomenon
of
cellular
plasticity
initially
reported
in
embryonic
development,
has
been
increasingly
recognized
for
its
importance
cancer
progression
and
metastasis.
Despite
tremendous
progress
being
made
the
past
2
decades
our
understanding
molecular
mechanism
functional
EMT
cancer,
there
are
several
mysteries
around
that
remain
unresolved.
In
this
Unsolved
Mystery,
we
focus
on
variety
types
metastasis,
cooperative
collective
behaviors,
spatiotemporal
characterization
EMT,
strategies
therapeutically
targeting
EMT.
We
also
highlight
new
technical
advances
will
facilitate
efforts
to
elucidate
unsolved
Theranostics,
Journal Year:
2024,
Volume and Issue:
14(7), P. 2946 - 2968
Published: Jan. 1, 2024
Recent
advancements
in
modern
science
have
provided
robust
tools
for
drug
discovery.
The
rapid
development
of
transcriptome
sequencing
technologies
has
given
rise
to
single-cell
transcriptomics
and
single-nucleus
transcriptomics,
increasing
the
accuracy
accelerating
discovery
process.
With
evolution
spatial
(ST)
technology
emerged
as
a
derivative
approach.
Spatial
hot
topic
field
omics
research
recent
years;
it
not
only
provides
information
on
gene
expression
levels
but
also
offers
expression.
This
shown
tremendous
potential
disease
understanding
In
this
article,
we
introduce
analytical
strategies
review
its
applications
novel
target
mechanism
unravelling.
Moreover,
discuss
current
challenges
issues
that
need
be
addressed.
conclusion,
new
perspective
Cancer Letters,
Journal Year:
2024,
Volume and Issue:
585, P. 216661 - 216661
Published: Feb. 2, 2024
Inhibitory
immune
checkpoint
(ICP)
molecules
are
pivotal
in
inhibiting
innate
and
acquired
antitumor
responses,
a
mechanism
frequently
exploited
by
cancer
cells
to
evade
host
immunity.
These
evasion
strategies
contribute
the
complexity
of
progression
therapeutic
resistance.
For
this
reason,
ICP
have
become
targets
for
drugs,
particularly
monoclonal
antibodies,
collectively
referred
as
inhibitors
(ICI),
that
counteract
such
cancer-associated
suppression
restore
responses.
Over
last
decade,
however,
it
has
clear
tumor
cell-associated
ICPs
can
also
induce
cell-intrinsic
effects,
particular
epithelial-mesenchymal
transition
(EMT)
macroautophagy
(hereafter
autophagy).
Both
these
processes
profound
implications
metastasis
drug
responsiveness.
This
article
reviews
positive
or
negative
cross-talk
undergo
with
autophagy
EMT.
We
discuss
upregulated
response
same
stimuli
Moreover,
themselves,
when
overexpressed,
an
EMT-inducing
stimulus.
As
regards
autophagy,
been
shown
either
stimulate
inhibit
while
itself
up-
downregulate
expression
ICPs.
dynamic
equilibrium
extends
autophagy-apoptosis
axis,
further
emphasizing
complexities
cellular
Eventually,
we
delve
into
intricate
balance
between
apoptosis,
elucidating
its
role
broader
interplay
dynamics
influenced
In
final
part
article,
speculate
about
driving
forces
underlying
contradictory
outcomes
reciprocal,
inhibitory,
stimulatory
effects
ICPs,
EMT,
autophagy.
A
conclusive
identification
may
allow
achieve
improved
using
combinations
ICIs
compounds
acting
on
EMT
and/or
Prospectively,
translate
increased
broadened
efficacy
compared
what
is
currently
achieved
ICI-based
clinical
protocols.
Journal of Cancer Research and Clinical Oncology,
Journal Year:
2024,
Volume and Issue:
150(6)
Published: June 8, 2024
Spatial
transcriptomics
(ST)
provides
novel
insights
into
the
tumor
microenvironment
(TME).
ST
allows
quantification
and
illustration
of
gene
expression
profiles
in
spatial
context
tissues,
including
both
cancer
cells
which
they
are
found.
In
research,
has
already
provided
metastasis,
prognosis,
immunotherapy
responsiveness.
The
clinical
precision
oncology
application
next-generation
sequencing
(NGS)
RNA
profiling
tumors
relies
on
bulk
methods
that
lack
context.
ability
to
preserve
information
is
now
possible,
as
it
us
capture
heterogeneity
multifocality.
this
narrative
review,
we
summarize
oncology,
discuss
clinic,
review
available
research
methods,
seqFISH,
MERFISH
(Vizgen),
CosMx
SMI
(NanoString),
Xenium
(10x),
Visium
Stereo-seq
(STOmics),
GeoMx
DSP
(NanoString).
We
then
current
literature
with
a
focus
solid
organized
by
type.
Finally,
conclude
addressing
an
important
question:
how
will
ultimately
help
patients
cancer?